ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION AND CHRONIC ISCHEMIC HEART DISEASE
被引:1
|
作者:
Rychkov, A. Yu
论文数: 0引用数: 0
h-index: 0
机构:
Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tomsk, RussiaRussian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tomsk, Russia
Rychkov, A. Yu
[1
]
Khorkova, N. Yu
论文数: 0引用数: 0
h-index: 0
机构:
Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tomsk, RussiaRussian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tomsk, Russia
Khorkova, N. Yu
[1
]
机构:
[1] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tomsk, Russia
The review is devoted to the use of antithrombotic therapy in patients with atrial fibrillation (AF) and chronic ischemic heart disease (IHD). We discuss data of international registries, meta-analyses assessing possibilities of the use of oral anticoagulants for secondary prevention of IHD. We present here results of randomized and observational clinical studies demonstrating advantages of prescription of monotherapy with oral anticoagulants (OAC) in combination of AF and chronic IHD. Modern evidence base of advantages of dual antithrombotic therapy with the use of direct OAC following percutaneous coronary intervention is also presented.
机构:
Columbia Univ, Milstein Hosp, Med Ctr, 177 Ft Washington Ave, New York, NY 10032 USAColumbia Univ, Milstein Hosp, Med Ctr, 177 Ft Washington Ave, New York, NY 10032 USA